BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Excessive Daytime Sleepiness News and Headlines
Excessive Daytime Sleepiness News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Excessive Daytime Sleepiness news alerts.
Site Map > Biotechnology News > Health News > Excessive Daytime Sleepiness
 

Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
PR Newswire:  similar ...
Vanda Pharmaceuticals Initiates Phase II Clinical Trial for VSF-173 in Excessive Sleepiness
Women's Health Weekly via NewsRx.com:  similar ...
Vanda Pharmaceuticals Initiates Phase II Clinical Trial for VSF-173 in Excessive Sleepiness
PR Newswire:  similar ...
Cephalon Receives Approvable Letter for NUVIGIL(TM) (armodafinil)
PR Newswire:  similar ...
Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of Excessive Daytime Sleepiness in Patients With Narcolepsy
PR Newswire:  similar ...
Cephalon Files New Drug Application for NUVIGIL(TM)
PR Newswire:  similar ...
Orphan Medical Submits Xyrem sNDA to Include Improvement in Other Primary Symptoms of Narcolepsy; Approval Would Expand Addressable Market to Over
Business Wire:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 
BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.